Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Brief description of study
The purpose of this research study is to see the short-term and long-term effects of topiramate on alcohol dependence comorbid (co-occurring) with post-traumatic stress disorder (PTSD). To assess whether topiramate is a safe and feasible treatment for alcohol dependence comorbid with PTSD, the effects of topiramate and specific genes on alcohol dependence, measurements of brain responses to stimulation of specific brain areas, and comparisons of blood markers and brain markers to determine differences in blood markers/brain markers in those taking topiramate versus those taking placebo. The use of topiramate in this study is investigational because topiramate is not FDA-approved to treat alcohol dependence comorbid with PTSD.
Our study teams will respond to the messages between normal office hours of 9AM to 5PM Monday through Fridays, excluding holidays. If this is a medical or psychiatric emergency, please dial 911 or walk to the nearest emergency room.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.